SEC Filing Analysis: GoodRx Holdings, Inc. (GDRX)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director acquired 20,521 shares of Class A Common Stock as part of a pre-scheduled RSU vesting, which is a standard compensation event, not a discretionary market trade.
• Market Impact: The impact is neutral as this is a routine, non-cash transaction with minimal dilutive effect on existing shareholders.

Company Information

Field	Value
Company	GoodRx Holdings, Inc.
Ticker Symbol	GDRX
CIK	0001809519
Industry	SERVICES-COMPUTER PROCESSING & DATA PREPARATION

Insider Information

Field	Value
Name	Hirsch Douglas Joseph
CIK	0001822522
Title/Position	null
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-26
Transaction Code	M (Exercise/Vesting of derivative)
Security Type	Class A Common Stock
Shares Involved	20,521
Price Per Share	$0.00
Total Value	$0
Shares Owned After (Direct)	231,909
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.00%
Shares Transacted	20,521
% of Shares Outstanding	0.021%
Post-Transaction Ownership (Beneficial)	2,864,630 shares (2.91% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction value is $0, making it immaterial against the company's $1.37 billion market capitalization.
• Ownership Concentration: Following the transaction, the insider beneficially owns approximately 2.91% of the company's outstanding shares through direct and indirect holdings (via DH 2024-2 GRAT). This vesting slightly increases an already significant holding.
• Dilution Impact: The issuance of 20,521 new shares represents approximately 0.021% of the total shares outstanding. This is a negligible dilutive event for existing shareholders and is a typical cost of equity-based compensation.
• Transaction Significance: The transaction is rated 'Low' significance. The 'M' code indicates the conversion of a derivative (RSU) into common stock, not an open-market purchase reflecting new investment sentiment. The number of shares is very small relative to the company's total shares outstanding.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The market generally does not react to RSU vestings as they are anticipated compensation events and do not represent an insider's discretionary decision to invest personal capital at current market prices.

Volume & Sentiment

• Expected Volume Impact: Minimal to none. This transaction does not involve open-market activity.
• Sentiment Indicator: Neutral. This filing confirms a scheduled compensation event and does not provide new bullish or bearish signals.

Investment Insights

Positive Market Indicators

• The insider continues to hold a substantial position in the company, aligning their interests with shareholders.

Risk Factors

• No new risk factors are indicated by this routine filing.

Key Takeaways

1. Routine Compensation: This is a non-discretionary transaction resulting from the vesting of Restricted Stock Units (RSUs) granted previously.
2. No Market Signal: Unlike an open-market buy or sell, this event does not signal a change in the insider's confidence in the company's future prospects.
3. Negligible Dilution: The impact on the total number of shares outstanding is minimal (0.021%), posing no significant dilution concern for investors.

Additional Context

Transaction Notes

• Footnotes: Footnote F1 clarifies that the transaction is the conversion of RSUs into common stock. Footnote F4 indicates the vesting schedule is one-third of the award on each of the first three anniversaries of the grant date, beginning October 26, 2025. This filing represents the first of these vesting tranches.
• Special Circumstances: The insider also has significant indirect holdings through Grantor Retained Annuity Trusts (GRATs), as detailed in the filing's non-derivative holdings section.